MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$32,739K
Unrealized gain on
marketable securities
$27K
Net loss
-$32,766K
Other income, net
$1,659K
Loss before income
tax expense
-$32,738K
Income tax expense
$28K
Total other income,
net
$1,659K
Operating loss
-$34,397K
Total operating
expenses
$34,397K
Research and development
$24,614K
General and
administrative
$9,783K
Back
Back
Income Statement
source: myfinsight.com
DiaMedica Therapeutics Inc. (DMAC)
DiaMedica Therapeutics Inc. (DMAC)